Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Werewolf Therapeutics Inc
HOWLCurrent price
1.12 USD
-0.02 USD (-1.75%)
Last closed
1.13 USD
Company
werewolftx.com
ISIN
US95075A1079
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
73 974 912 USD
Yield for 12 month
-81.36 %
1Y
3Y
5Y
10Y
15Y
HOWL
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule that is in Phase I/Ib clinical trial for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule, which is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; and WTX-712, an activated Interleukin-21(IL-21) and WTX-518, an activated IL-18 (IL-18) INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts. Address: 200 Talcott Ave, Watertown, MA, United States, 02472
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
12.00 USDP/E ratio
–Dividend Yield
–Current Year
+19 943 000 USD
Last Year
+16 401 000 USD
Current Quarter
–
Last Quarter
+1 143 000 USD
Current Year
-18 963 000 USD
Last Year
+16 401 000 USD
Current Quarter
–
Last Quarter
+689 000 USD
Key Figures HOWL
1 year
3 years
5 years
10 years
EBITDA
-64 376 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-26.16 %
PEG Ratio
–
Return On Equity TTM
-61.56 %
Wall Street Target Price
12.00 USD
Revenue TTM
3 386 000 USD
Book Value
2.04 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-85.90 %
Dividend Yield
–
Gross Profit TTM
-37 360 000 USD
Earnings per share
-1.52 USD
Diluted Eps TTM
-1.52 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics HOWL
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History HOWL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Stock Valuation HOWL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.67
Price Sales TTM
21.85
Enterprise Value EBITDA
0.57
Price Book MRQ
0.83
Financials HOWL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HOWL
For 52 weeks
1.58 USD
8.19 USD
50 Day MA
2.15 USD
Shares Short Prior Month
1 312 267
200 Day MA
3.44 USD
Short Ratio
2.09
Shares Short
1 234 994
Short Percent
4.67 %
BeatStart